N/A
Completed N=20
COVID-19 Vaccine Hesitancy Counseling Intervention for Pharmacists: A Stepped-Wedge Trial
Source: ClinicalTrials.gov NCT06547814 ↗Enrolled (actual)
20
Serious AEs
—
Results posted
Jan 2026
Primary outcomePrimary: Mean Fidelity Score — 18.1; 18.4 score on a scale
Summary
The goal of this clinical trial is to test if virtual facilitation (e.g., video coaching) increases rural pharmacists' ability to implement COVID-19 vaccine hesitancy counseling when compared to a "standard" implementation approach (e.g., training and dissemination of implementation support tools) in rural pharmacies. The main question it aims to answer is if virtual facilitation improves fidelity to a newly developed vaccine hesitancy counseling intervention when compared to standard implementation.
All participants will begin in the standard implementation condition, where they will complete a webinar on COVID-19 vaccinations and a 30-minute online training on vaccine hesitancy communication. After standard implementation, they will switch to the virtual facilitation condition where they will be assigned a virtual coach to help them with implementing the intervention. There will be six fidelity observations per each 8-week intervention period to determine whether pharmacists are implementing the intervention as intended. Researchers will compare fidelity between the standard and virtual facilitation conditions.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Mean Fidelity Score |
18.1; 18.4 | — |
| SECONDARY Proportion of Individuals Receiving Vaccine Hesitancy Counseling Who Chose to Get the COVID-19 Vaccine |
0.28; 0.31 | — |
Eligibility Criteria
Inclusion Criteria
- The pharmacy must be a member of the Rural Research Alliance for Community Pharmacies (RURAL-CP).
- The pharmacy must be located in a county that has an African American population of at least 25% or had at least 51% of the population vote for a Republican president in 2020.
Exclusion Criteria
- The pharmacy will be excluded if it does not offer COVID-19 vaccines.
Data sourced from ClinicalTrials.gov (NCT06547814). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.